Crescendo Bioscience, Inc. (NASDAQ:MYGN)

CAPS Rating: 4 out of 5

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products.

Caps

How do you think MYGN will perform against the market?

Add Stock to CAPS Watchlist

All Players

528 Outperform
87 Underperform
 

All-Star Players

112 Outperform
14 Underperform
 

Wall Street

19 Outperform
5 Underperform
 

Top MYGN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TSIF (99.97)
Submitted October 12, 2016

Interesting reaction in some regard. Tesero's testing on Nirapabib for ovarian-cancer had initially show that the DNA destroying drug should not be used by those with a Gene mutation in the BRCA drugs preventing the cells to be unable to be repaired.… More

Doggylad (< 20)
Submitted August 01, 2014

It relies on BRCA testing, which will see extreme price pressure from payors

MYGN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about MYGN.

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/3/2017 10:30:09 AM : Outperform Start Price: $19.34 MYGN Score: +46.84

Myriad reasons to buy this beaten down biotech? Well, maybe not, but there's hope for a comeback.Makes advanced tests for various hereditary cancers.

Recs

0
Member Avatar healthcarevalue (94.71) Submitted: 11/2/2016 7:54:34 PM : Outperform Start Price: $16.98 MYGN Score: +54.03

Myriad Genetics (MYGN). Cheap with price/earnings ratio last 12 months at about 11, in 2015 it was as high as just under 35 and in 2014 it was just about 19. Return on Invested Capital is good last 12 months at just under 17 and same for 06 2016 and just under 12 for 2015 and an impressive at about 24 in 2014. Negligible to no debt/equity ratio so financial health is quite good. Market cap at just about 1 billion leaves much room to grow, or be acquired especially with low price of stock and low debt levels. Area of diagnostic and medical testing is a high growth niche field.

Recs

1
Member Avatar TSIF (99.97) Submitted: 10/12/2016 8:23:18 AM : Outperform Start Price: $18.69 MYGN Score: +41.02

Interesting reaction in some regard. Tesero's testing on Nirapabib for ovarian-cancer had initially show that the DNA destroying drug should not be used by those with a Gene mutation in the BRCA drugs preventing the cells to be unable to be repaired. The conclusion was that both sets that they were using MYGN's gene testing to test for responded to the drug regardless. One had a 15 month approval in survival, one about 3 months.

Even if the FDA agrees....wouldn't you want the test anyway to help your patient understand their probably outcome?

MYGN without the test has decent revenue and potential. Reaction to Tesaro's news is excessive.

Target: Hold and observe actual earning and applications.

Leaderboard

Find the members with the highest scoring picks in MYGN.

Score Leader

conliskjr

conliskjr (< 20) Score: +278.80

The Score Leader is the player with the highest score across all their picks in MYGN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Afropuffashion < 20 2/27/2009 Underperform 1Y $40.00 -28.00% +233.68% +261.68 1 Comment
anticitradeshort 30.42 4/20/2009 Underperform NS $44.11 -34.71% +186.69% +221.40 0 Comment
mcornice 86.98 4/30/2009 Underperform 3M $39.68 -27.42% +176.85% +204.27 1 Comment
wofaintagain < 20 10/15/2009 Underperform 3M $26.30 +9.51% +122.40% +112.90 0 Comment
pinoyrags2riches 69.38 10/14/2009 Underperform NS $25.59 +12.54% +123.63% +111.09 0 Comment
dangerfall2010 < 20 2/26/2010 Underperform 5Y $22.52 +27.89% +119.25% +91.36 2 Comments
redbearish < 20 2/23/2010 Underperform 3M $22.38 +28.69% +118.93% +90.25 2 Comments
corkymilb < 20 7/7/2008 Underperform 1Y $26.33 +9.40% +97.48% +88.08 0 Comment
AITitus 82.14 7/3/2008 Underperform 1Y $26.29 +9.55% +97.03% +87.48 0 Comment
francygucci < 20 3/10/2010 Underperform 1Y $23.09 +24.73% +111.12% +86.39 2 Comments

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.81 4/18/2016 Underperform 3W $38.77 -25.72% +16.00% +41.71 0 Comment
TrackJGreenblatt 64.64 10/21/2014 Outperform 1Y $35.50 +16.28% +6.07% +10.21 10/21/2015 @ $41.28 1 Comment
TrackJMP 82.82 2/6/2014 Underperform NS $31.13 -7.48% +38.23% +45.72 0 Comment
TrackLadenburg < 20 11/7/2013 Outperform NS $25.36 +13.56% +36.74% -23.17 0 Comment
TrackCreditSuiss 90.30 10/21/2013 Underperform NS $24.20 +19.01% +39.13% +20.12 0 Comment
TrackCantorFitz 29.76 6/7/2013 Outperform NS $31.38 -8.22% +48.13% -56.35 0 Comment
trackmizuho < 20 5/8/2013 Outperform NS $30.83 -6.58% +49.43% -56.02 0 Comment
TrackZacks < 20 11/6/2012 Outperform 3M $30.65 -2.32% -3.13% +0.81 11/12/2012 @ $29.94 1 Comment
TrackWayneRogers 57.80 9/7/2012 Outperform 3M $26.83 +7.34% +68.16% -60.82 0 Comment
TrackGoldmanSach 71.67 7/2/2012 Outperform NS $24.14 +19.30% +77.84% -58.53 0 Comment
TrackPoisedTo < 20 5/23/2012 Outperform 5Y $25.66 +12.24% +84.92% -72.68 0 Comment
TrackZacks < 20 5/2/2012 Outperform 3M $26.45 -6.24% -6.75% +0.51 5/17/2012 @ $24.80 1 Comment
TrackCowenandCo 87.70 4/20/2012 Outperform NS $25.23 +14.15% +75.46% -61.31 0 Comment
TrackZacks < 20 2/28/2012 Outperform 3M $24.45 -3.35% +1.67% -5.03 4/4/2012 @ $23.63 1 Comment
TrackZacks < 20 2/1/2012 Underperform 3M $23.97 +2.00% +3.84% +1.84 2/28/2012 @ $24.45 1 Comment
TrackZacks < 20 11/11/2011 Outperform 3M $20.69 +5.65% +3.79% +1.87 1/19/2012 @ $21.86 1 Comment
TrackTiconderoga 87.90 11/2/2011 Outperform NS $23.85 +20.75% +96.00% -75.25 0 Comment
TrackAurigaUSA 35.36 9/12/2011 Outperform NS $18.29 +57.46% +112.03% -54.57 0 Comment
TrackZacks < 20 6/30/2011 Outperform 3M $22.71 -17.13% -14.65% -2.48 8/19/2011 @ $18.82 1 Comment
TrackGoldmanSach 71.67 2/28/2011 Underperform 5Y $18.43 +7.11% -7.29% -14.40 10/21/2011 @ $19.74 1 Comment
TrackRBCCapMkts 88.17 10/13/2010 Outperform NS $19.18 +50.16% +106.28% -56.12 0 Comment
TrackPatDorsey < 20 7/9/2010 Outperform 5Y $15.06 +95.55% +27.97% +67.58 11/9/2012 @ $29.45 0 Comment
trackgleachercom 54.50 6/16/2010 Underperform NS $17.84 +61.43% +117.83% +56.40 0 Comment
TrackZacks < 20 5/26/2010 Underperform 3M $18.50 -8.11% +8.28% +16.38 10/5/2010 @ $17.00 1 Comment
TrackAurigaUSA 35.36 5/13/2010 Outperform NS $18.93 +23.03% +9.42% +13.62 6/15/2011 @ $23.29 0 Comment
TrackJPMorgan 88.97 4/26/2010 Outperform NS $23.16 +3.63% -2.49% +6.12 4/30/2010 @ $24.00 0 Comment
TrackAurigaUSA 35.36 3/5/2010 Underperform NS $22.66 -16.46% +3.43% +19.89 5/13/2010 @ $18.93 0 Comment
TrackOppenheimer 64.36 3/4/2010 Underperform NS $22.95 +25.49% +115.84% +90.35 0 Comment
TrackZacks < 20 11/6/2009 Underperform 3M $24.38 -0.49% +2.85% +3.34 12/18/2009 @ $24.26 1 Comment
TrackCanaccord 58.54 8/27/2009 Outperform NS $28.74 +0.21% +137.13% -136.92 0 Comment
TrackWMBlair 75.98 8/4/2009 Outperform NS $27.16 +6.04% +143.92% -137.88 0 Comment
TrackSoleil 97.56 7/17/2009 Outperform NS $25.63 +12.37% +159.28% -146.91 0 Comment
TrackMorganJos 78.80 7/1/2009 Underperform NS $27.16 -8.80% +19.29% +28.09 11/11/2009 @ $24.77 0 Comment
TrackPiperJaff 84.75 7/1/2009 Outperform NS $27.16 +6.04% +163.99% -157.95 0 Comment
TrackMorganJos 78.80 5/19/2009 Outperform NS $33.44 -18.78% +1.62% -20.40 7/1/2009 @ $27.16 0 Comment
TrackJimCramer 84.81 4/1/2009 Outperform 3W $45.07 -13.98% +158.13% -172.11 4/18/2016 @ $38.77 0 Comment
TrackLeerinkSwan 98.18 3/24/2009 Outperform NS $40.71 -29.26% +202.83% -232.09 0 Comment
TrackZacks < 20 2/4/2009 Outperform 3M $41.56 -41.33% +28.56% -69.89 11/7/2009 @ $24.38 1 Comment
trackbenchmark 99.66 2/3/2009 Outperform NS $42.46 -32.17% +199.02% -231.18 0 Comment
TrackCitigroup 93.22 11/21/2008 Outperform NS $31.24 -7.80% +222.88% -230.67 0 Comment
TrackOppenheimer 64.36 10/8/2008 Outperform NS $29.14 -6.79% -4.82% -1.98 7/1/2009 @ $27.16 0 Comment
TrackRBCCapMkts 88.17 7/30/2008 Outperform NS $32.23 -15.72% -27.06% +11.34 7/1/2009 @ $27.16 0 Comment
TrackCanaccord 58.54 6/5/2008 Underperform NS $23.86 +20.45% -26.41% -46.86 8/26/2009 @ $28.74 0 Comment
TrackRBCCapMkts 88.17 5/28/2008 Underperform NS $24.62 -9.40% -8.20% +1.20 6/30/2008 @ $22.30 0 Comment
TrackGarpResearc < 20 11/28/2007 Outperform NS $23.64 +21.83% +76.36% -54.53 0 Comment
TrackZacks < 20 8/21/2007 Outperform 3M $21.02 +55.84% -11.97% +67.81 8/20/2008 @ $32.75 1 Comment
TrackUBS 93.54 2/8/2007 Outperform NS $17.83 +61.53% +77.93% -16.41 0 Comment
TrackBroadpointAmTech < 20 2/8/2007 Outperform NS $17.83 +35.00% -4.63% +39.63 4/17/2012 @ $24.07 0 Comment
TrackJMP 82.82 2/7/2007 Outperform NS $17.92 +78.51% +20.76% +57.75 2/5/2014 @ $31.98 0 Comment
TrackBofASec 94.65 11/2/2006 Outperform NS $13.31 +132.84% +20.01% +112.84 6/14/2013 @ $30.98 0 Comment

Featured Broker Partners